Real-world Use of Molecular Point-of-care Testing for Sexually Transmitted Infections (STIs) in the Emergency Department: Why It Matters for Acute Care Management - Report - MDSpire
Advertisement
Real-world Use of Molecular Point-of-care Testing for Sexually Transmitted Infections (STIs) in the Emergency Department: Why It Matters for Acute Care Management
Clinical Report: Molecular POC Testing for STIs in Emergency Departments
Overview
Implementation of molecular point-of-care (POC) PCR testing for Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis in an emergency department significantly reduced patient length of stay and rates of overtreatment compared to central laboratory testing. The study demonstrated improved targeted treatment and workflow efficiency in acute care settings.
Background
Sexually transmitted infections (STIs) such as Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis are common in emergency department (ED) patients, particularly among vulnerable populations. Traditional ED management relies on syndromic diagnosis and empiric antimicrobial treatment due to delays in laboratory confirmation, leading to overtreatment and undertreatment. Rapid nucleic acid amplification tests (NAATs) have improved diagnostic accuracy but typically require 1 to 2 days for results. Recently, FDA-cleared molecular POC PCR assays have become available, enabling definitive diagnosis and treatment during a single ED visit.
Data Highlights
Parameter
Central Laboratory Testing
ED POC PCR Testing
Difference
Statistical Significance
Number of patients
340
287
-
-
Length of Stay (LOS)
Reference
76 minutes shorter (9.3% reduction)
-76 minutes
P = .017
Overtreatment rate for CT
Reference
73% reduction
-73%
P < .001
Overtreatment rate for NG
Reference
63% reduction
-63%
P = .002
Undertreatment rate for any CT/NG/TV-positive
Reference
67% reduction (not statistically significant)
-67%
P = .093
Key Findings
ED POC PCR testing reduced emergency department length of stay by an average of 76 minutes (9.3% reduction; P = .017).
Overtreatment rates for Chlamydia trachomatis decreased by 73% with POC testing (P < .001).
Overtreatment rates for Neisseria gonorrhoeae decreased by 63% with POC testing (P = .002).
There was a 67% lower rate of undertreatment for any CT/NG/TV-positive patients with POC testing, though this was not statistically significant (P = .093).
POC testing enabled organism-specific targeted treatment, improving antimicrobial stewardship in the ED.
Implementation of POC testing required integration into ED workflow but demonstrated feasibility and clinical benefit.
Clinical Implications
Molecular POC PCR testing for STIs in the ED allows for rapid, accurate diagnosis and targeted treatment during the patient encounter, reducing unnecessary antimicrobial use and improving patient flow. Adoption of POC testing can enhance antimicrobial stewardship and potentially reduce community transmission by minimizing overtreatment and undertreatment. Clinicians should consider integrating POC STI testing into ED protocols to optimize acute care management.
Conclusion
The integration of molecular POC PCR testing for STIs in emergency departments significantly improves clinical management by shortening length of stay and reducing overtreatment, supporting its adoption as a standard diagnostic approach in acute care settings.
References
Johns Hopkins Hospital Study 2023 -- Practical Application of Molecular Point-of-Care Testing for STIs in EDs
by Gaby Dashler, Kendall Maliszewski, Mustapha Saheed, Edana Mann, Nyah Johnson, Spencer J Mann, Tracy Colburn, William Clarke, Charlotte A Gaydos, Yukari C Manabe, K Davina Frick, Richard E Rothman, Yu-Hsiang Hsieh